Loading clinical trials...
Loading clinical trials...
Physical Performance and Analgesic Effects of tDCS in Primary Dysmenorrhea: A Randomized, Double Blind Clinical Trial
Technological advances and non-invasive techniques to modulate brain function have been developed, including transcranial Direct Current Stimulation (tDCS). Basically, electrodes are placed on the brain regions to stimulate or inhibit it. Subsequently, a continuous electrical current (0.4-2 mA) is imposed, for a period of 3-20 minutes, to modify cortical excitability. Few are the research groups that work on the topic of primary dysmenorrhea and the use of tDCS as the focus of study. Preliminary studies associated the use of tDCS with pain reduction, but the outcomes of physical and behavioral function needs further investigation.
Age
18 - 60 years
Sex
FEMALE
Healthy Volunteers
No
Federal University of Rio Grande do Norte
Santa Cruz, Rio Grande do Norte, Brazil
Start Date
June 1, 2017
Primary Completion Date
July 31, 2017
Completion Date
August 31, 2017
Last Updated
September 12, 2017
20
ACTUAL participants
Active Transcranial Direct Current Stimulation
DEVICE
Sham Transcranial Direct Current Stimulation
DEVICE
Lead Sponsor
Universidade Federal do Rio Grande do Norte
NCT06346132
NCT07351968
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions